Hakutulokset - Gisèle Bonne

Tarkenna hakua
  1. 1
    Emery–Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies

    Emery–Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies Tekijä Gisèle Bonne, Susana Quijano-Roy

    Julkaistu 2013
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    “Laminopathies”: A wide spectrum of human diseases

    “Laminopathies”: A wide spectrum of human diseases Tekijä Howard J. Worman, Gisèle Bonne

    Julkaistu 2007
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Emery-Dreifuss muscular dystrophy

    Emery-Dreifuss muscular dystrophy Tekijä A. Leclerc, Gisèle Bonne, Ketty Schwartz

    Julkaistu 2002
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    The 2018 version of the gene table of monogenic neuromuscular disorders (nuclear genome)

    The 2018 version of the gene table of monogenic neuromuscular disorders (nuclear genome) Tekijä Gisèle Bonne, François Rivier, Dalil Hamroun

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome

    Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome Tekijä Rachel Thompson, Gisèle Bonne, Paolo Missier, Hanns Lochmüller

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    The 2020 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2020 version of the gene table of neuromuscular disorders (nuclear genome) Tekijä Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    The 2021 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2021 version of the gene table of neuromuscular disorders (nuclear genome) Tekijä Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    The 2022 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2022 version of the gene table of neuromuscular disorders (nuclear genome) Tekijä Enzo Cohen, Gisèle Bonne, François Rivier, Dalil Hamroun

    Julkaistu 2021
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    The 2023 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2023 version of the gene table of neuromuscular disorders (nuclear genome) Tekijä Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Julkaistu 2022
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    The 2024 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2024 version of the gene table of neuromuscular disorders (nuclear genome) Tekijä Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Julkaistu 2023
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Expression of human cytochrome <i>c</i>, oxidase subunits during fetal development

    Expression of human cytochrome <i>c</i>, oxidase subunits during fetal development Tekijä Gisèle Bonne, Peter Seibel, Stefanie Possekel, C. Marsac, Bernhard Kadenbach

    Julkaistu 1993
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C Gene

    Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C Gene Tekijä Wei Wu, Antoine Muchir, Jian Shan, Gisèle Bonne, Howard J. Worman

    Julkaistu 2010
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene

    Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene Tekijä Wei Wu, Jian Shan, Gisèle Bonne, Howard J. Worman, Antoine Muchir

    Julkaistu 2010
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery–Dreifuss muscular dystrophy

    Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery–Dreifuss muscular dystrophy Tekijä Antoine Muchir, Paul Pavlidis, Gisèle Bonne, Yukiko Hayashi, Howard J. Worman

    Julkaistu 2007
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins

    Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins Tekijä Antoine Muchir, Jing Shan, Gisèle Bonne, Stephan E. Lehnart, Howard J. Worman

    Julkaistu 2008
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    ColVI myopathies: where do we stand, where do we go?

    ColVI myopathies: where do we stand, where do we go? Tekijä Valérie Allamand, Laura Briñas, Pascale Richard, Tanya Stojkovic, Susana Quijano‐Roy, Gisèle Bonne

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Autophagic degradation of nuclear components in mammalian cells

    Autophagic degradation of nuclear components in mammalian cells Tekijä Young-Eun Park, Yukiko Hayashi, Gisèle Bonne, Takuro Arimura, S. Noguchi, Ikuya Nonaka, Ichizo Nishino

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Primary Prevention of Sudden Death in Patients with Lamin A/C Gene Mutations

    Primary Prevention of Sudden Death in Patients with Lamin A/C Gene Mutations Tekijä Christophe Meune, Jop H. van Berlo, Frédéric Anselme, Gisèle Bonne, Yigal M. Pinto, Denis Duboc

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy

    Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy Tekijä Anne-Claire Guénantin, Imen Jebeniani, Julia Leschik, Erwan Watrin, Gisèle Bonne, Nicolas Vignier, Michel Pucéat

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene

    Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene Tekijä Antoine Muchir, Sarah A Reilly, W. Wu, Shinichi Iwata, Shunichi Homma, Gisèle Bonne, Howard J. Worman

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: